3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
4
Adenocarcinoma of Lung
2
Recurrence
1
Non-Small Cell Lung Cancer Without Mutation in Epidermal Growth Factor Receptor (Disorder)
1
Neoplasms
1
Liver Neoplasms
1
Glioblastoma
1
Esophageal Squamous Cell Carcinoma
1
Endometrial Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Advanced Solid Tumor
1
Interventions
Radiosurgery
7
lenvatinib
5
Radiofrequency Ablation
5
Electroporation
5
Radiotherapy
3
Patient Navigation
3
Laparoscopy
3
Hepatectomy
3
Exercise
3
sintilimab
2
perflutren
2
Surgical Procedures, Operative
2
Standard of Care
2
Proton Therapy
2
Nutritional Status
2
Magnetic Resonance Spectroscopy
2
Liver Transplantation
2
Injections
2
Dextrins
2
Cryosurgery
2
Control Groups
2
Bupivacaine
2
Anesthesia, General
2
toripalimab
1
tislelizumab
1
seocalcitol
1
pembrolizumab
1
motexafin gadolinium
1
gadofosveset trisodium
1
gadobutrol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Liver Neoplasms
×
tislelizumab
×
Clear all
NCT05339581
2022-04-27
iPLENTY-pvtt
RenJi Hospital
Phase NA
Unknown
78 enrolled